ProUroCare Medical Inc., a Nevada Corporation (OTCQB: PUMD), developer of the FDA-approved ProUroScan™ prostate imaging system, announced today that it intends to remove its common stock...
ProUroCare Medical Inc. (OTCQB: PUMD) is pleased to announce the appointment of Stan Myrum as Interim CEO of the company and as a Director on its Board of Directors. Stan has over 30 years...
ProUroCare Medical Inc. (OCTQB: PUMD), developer of the FDA-approved ProUroScan™ prostate imaging system, announced that life sciences veteran Doris Engibous has entered into...
ProUroCare Medical Inc. (OCTQB: PUMD), a provider of proprietary medical imaging products, today announced that Dr. David M. Barrett, MD, was elected to ProUroCare’s Board of...
ProUroCare Medical Inc., (OTCQB: PUMD), a provider of proprietary medical imaging products, announced today it has appointed Stan Myrum a consultant to lead its technology and...
ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System Approved to make real-time, color images of men's prostate glands, ProUroCare will next pilot the clinical...
ProUroCare Medical Elects Larry W. Getlin as New Director PR Newswire MINNEAPOLIS, July 7, 2011 MINNEAPOLIS, July 7, 2011 /PRNewswire/ -- ProUroCare Medical Inc. (OTCQB: PUMD), a provider of...
UPDATE - ProUroCare Announces $3 Million Financing Agreement PR Newswire MINNEAPOLIS, Sept. 29 MINNEAPOLIS, Sept. 29 /PRNewswire-FirstCall/ -- ProUroCare Medical Inc. (OTC Bulletin Board: PUMD...
ProUroCare Announces $3 Million Financing Agreement PR Newswire MINNEAPOLIS, Sept. 28 MINNEAPOLIS, Sept. 28 /PRNewswire-FirstCall/ -- ProUroCare Medical Inc. (OTC Bulletin Board: PUMD), a...
ProUroCare Medical Inc. Announces Completion of Warrant Replacement Offering PR Newswire EDEN PRAIRIE, Minn., Aug. 5 EDEN PRAIRIE, Minn., Aug. 5 /PRNewswire-FirstCall/ -- ProUroCare Medical Inc...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
52 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
156 | 0 | 0 | 0.0001 | 0.0002 | 0.0001 | 16245 | 0.00013718 | CS |
260 | -0.002764 | -96.5083798883 | 0.002864 | 0.0034 | 1.0E-6 | 42915 | 0.00107167 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales